GleamWall
中文EN

INMD InMode Ltd. Annual reports only

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1742692 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-6.2%
TTM net income YoY-48.2%
TTM EPS YoY-36.4%
Revenue 3-yr CAGR-6.6%
Net income 3-yr CAGR-16.6%

Margins

Gross margin78.5%
Operating margin23.0%
Net margin25.3%
FCF margin22.7%
EBITDA margin23.2%

Returns

ROE13.5%
ROA12.1%
ROIC (approx.)15.6%
Asset turnover0.48x

Leverage & solvency

Liabilities / assets10.9%
Debt / equity0.00x
Current ratio9.88x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.91x
Accruals ratio1.1%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY2025*2025-12-31FY2024*2024-12-31
Income statement
Revenue$370.50M$394.82M
Cost of revenue$79.53M$77.75M
Gross profit$290.97M$317.07M
R&D expense$13.32M$13.14M
SG&A expense$11.69M$10.03M
Operating income$85.39M$112.53M
Pretax income$110.33M$143.47M
Income tax$16.50M-$37.81M
Net income$93.83M$181.28M
EBITDA$86.08M$113.26M
EPS (basic)1.452.29
EPS (diluted)1.432.25
Weighted avg. shares (diluted)65.44M80.60M
Balance sheet
Cash & equivalents$302.54M$155.33M
Short-term investments$83.63M$267.69M
Receivables$43.50M$36.34M
Inventory$74.05M$59.55M
Current assets$698.62M$714.45M
PP&E, net$2.60M$2.32M
Total assets$766.43M$785.67M
Current liabilities$70.74M$69.85M
Total liabilities$83.23M$81.85M
Shareholders' equity$683.20M$703.81M
Shares outstanding63.36M69.56M
Cash flow statement
Operating cash flow$85.26M$132.66M
Capital expenditure$972,000$669,000
Free cash flow$84.28M$132.00M
Investing cash flow$186.03M$162.21M
Financing cash flow-$126.06M-$282.77M
Depreciation & amortization$695,000$728,000
Stock-based compensation$11.13M$16.57M
Share buybacks$127.44M$285.38M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.